Home › Head and Neck Squamous Cell Carcinoma › Texas › San Antonio

Head and Neck Squamous Cell Carcinoma clinical trials in San Antonio, TX

22 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

RecruitingPhase 1

South Texas Accelerated Research Therapeutics (START), San Antonio

Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06465069

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

RecruitingPhase 1

NEXT Oncology, San Antonio

Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07090499

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

RecruitingPhase 1

NEXT Oncology - PARENT, San Antonio

Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07360314

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

RecruitingPhase 1/2

START South Texas Accelerated Research Therapeutics, San Antonio

Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05267626

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

RecruitingPhase 1/2

START Center for Cancer Research, San Antonio

Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07109726

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

RecruitingObservational study

The University of Texas Health Science Center at San Antonio, San Antonio

Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2

NEXT Oncology - San Antonio, San Antonio

Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06657222

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

RecruitingPhase 1

Site 102 - START San Antonio, San Antonio

Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07462377

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

RecruitingPhase 1

START San Antonio, San Antonio

Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06597721

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

RecruitingPhase 1

START-San Antonio, San Antonio

Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT06084481

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2

Research Site, San Antonio

Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07115043

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

RecruitingPhase 1

Normunity Investigational Site, San Antonio

Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07182149

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2

START San Antonio, San Antonio

Ages 18 and older · All sexes · Updated Aug 13, 2026 · NCT05985655

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

RecruitingPhase 1

NEXT Virginia, LLC, San Antonio
South Texas Accelerated Research Therapeutics, LLC, San Antonio

Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT05208762

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RecruitingPhase 1/2

START San Antonio, San Antonio

Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2

START, San Antonio

Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06993844

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

RecruitingPhase 1

NEXT Oncology /ID# 243007, San Antonio
South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio

Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT05005403

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

RecruitingPhase 1

NEXT Texas LLC - San Antonio, San Antonio
START San Antonio, LLC, San Antonio

Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT07503808

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

RecruitingPhase 3

GSK Investigational Site, San Antonio

Ages 18 and older · All sexes · Updated May 26, 2026 · NCT06256588

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

RecruitingPhase 1

NEXT Oncology, San Antonio

Ages 18 and older · All sexes · Updated Apr 2, 2026 · NCT06451497

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2

START San Antonio, San Antonio

Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT07030257

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

RecruitingPhase 1

Dren Investigational Site, San Antonio

Ages 18 and older · All sexes · Updated Jan 7, 2026 · NCT06999187

Head and Neck Squamous Cell Carcinoma trials in other cities

Other studies in San Antonio

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.